Evidence map›Paper›PMID 34478772›Full record

ArticleNeurotoxicology2021

Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus.

Jonas J Calsbeek, Eduardo A González, Casey A Boosalis, Dorota Zolkowska, Donald A Bruun, Douglas J Rowland, Naomi H Saito, Danielle J Harvey, Abhijit J Chaudhari, Michael A Rogawski and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Neurotoxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Quantitative TNeuropharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jonas J CalsbeekDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA, 95616, USA. Electronic address: jcalsbeek@ucdavis.edu.
Eduardo A GonzálezDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA, 95616, USA. Electronic address: azgonzalez@ucdavis.edu.
Casey A BoosalisDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA, 95616, USA. Electronic address: caboosalis@ucdavis.edu.
Dorota ZolkowskaDepartment of Neurology, University of California, Davis, School of Medicine, Davis, CA, 95616, USA. Electronic address: djrowland@ucdavis.edu.
Donald A BruunDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA, 95616, USA. Electronic address: dabruun@ucdavis.edu.
Douglas J RowlandCenter for Molecular and Genomic Imaging, University of California, Davis, College of Engineering, Davis, CA, 95616, USA. Electronic address: dzolkowska@ucdavis.edu.
Naomi H SaitoDepartment of Public Health Sciences, University of California, Davis, School of Medicine, Davis, CA, 95616, USA. Electronic address: nhsaito@ucdavis.edu.
Danielle J HarveyDepartment of Public Health Sciences, University of California, Davis, School of Medicine, Davis, CA, 95616, USA. Electronic address: djharvey@ucdavis.edu.
Abhijit J ChaudhariCenter for Molecular and Genomic Imaging, University of California, Davis, College of Engineering, Davis, CA, 95616, USA. Electronic address: ajchaudhari@ucdavis.edu.
Michael A RogawskiDepartment of Neurology, University of California, Davis, School of Medicine, Davis, CA, 95616, USA. Electronic address: rogawski@ucdavis.edu.
Joel R GarbowBiomedical Magnetic Resonance Laboratory, Mallinckrodt Institute of Radiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, 63110, USA. Electronic address: garbow@wustl.edu.
Pamela J LeinDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA, 95616, USA. Electronic address: pjlein@ucdavis.edu.
University of California, Davis · USWashington University in St. Louis · US

Funding

Training and Education CoreU54NS079202 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEIN, PAMELA J · 2012 to 2021
$35.7M
WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JEFFREY D MILBRANDT · 2020 to 2026
$15.5M
UC Davis Biology ProgramR25GM056765 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI GOMES, ALDRIN V. · 1998 to 2019
$9.7M
Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Evaluating microglial activation as a pathogenic mechanism contributing to persistent neurological damage following acute intoxication of the juvenile brain with diisopropylfluorophosphate (DFP)F31NS110522 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GONZALEZ, EDUARDO AZTLAN · 2019 to 2020
$76k
NICHD NIH HHS P50 HD103525NICHD NIH HHS P50 HD103526NIGMS NIH HHS R25 GM056765NINDS NIH HHS F31 NS110522NINDS NIH HHS U54 NS079202
6 · The paper itself

Abstract

Acute intoxication with tetramethylenedisulfotetramine (TETS) can trigger status epilepticus (SE) in humans. Survivors often exhibit long-term neurological effects, including electrographic abnormalities and cognitive deficits, but the pathogenic mechanisms linking the acute toxic effects of TETS to chronic outcomes are not known. Here, we use advanced in vivo imaging techniques to longitudinally monitor the neuropathological consequences of TETS-induced SE in two different mouse strains. Adult male NIH Swiss and C57BL/6J mice were injected with riluzole (10 mg/kg, i.p.), followed 10 min later by an acute dose of TETS (0.2 mg/kg in NIH Swiss; 0.3 mg/kg, i.p. in C57BL/6J) or an equal volume of vehicle (10% DMSO in 0.9% sterile saline). Different TETS doses were administered to trigger comparable seizure behavior between strains. Seizure behavior began within minutes of TETS exposure and rapidly progressed to SE that was terminated after 40 min by administration of midazolam (1.8 mg/kg, i.m.). The brains of vehicle and TETS-exposed mice were imaged using in vivo magnetic resonance (MR) and translocator protein (TSPO) positron emission tomography (PET) at 1, 3, 7, and 14 days post-exposure to monitor brain injury and neuroinflammation, respectively. When the brain scans of TETS mice were compared to those of vehicle controls, subtle and transient neuropathology was observed in both mouse strains, but more extensive and persistent TETS-induced neuropathology was observed in C57BL/6J mice. In addition, one NIH Swiss TETS mouse that did not respond to the midazolam therapy, but remained in SE for more than 2 h, displayed robust neuropathology as determined by in vivo imaging and confirmed by FluoroJade C staining and IBA-1 immunohistochemistry as readouts of neurodegeneration and neuroinflammation, respectively. These findings demonstrate that the extent of injury observed in the mouse brain after TETS-induced SE varied according to strain, dose of TETS and/or the duration of SE. These observations suggest that TETS-intoxicated humans who do not respond to antiseizure medication are at increased risk for brain injury.

Indexed as

AnimalsBrainBridged-Ring CompoundsMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLMidazolamNeuroimagingNeuroinflammatory DiseasesPositron-Emission TomographyRiluzoleSeizuresSpecies SpecificityStatus EpilepticusBridged-Ring CompoundsMidazolamRiluzoletetramethylenedisulfotetramineMRINeurodegenerationNeuroinflammationPETTetramine

Identifiers

PMID34478772
PMCPMC8595842
OpenAlexW3196334965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.